Patents Represented by Attorney Hoxie & Assoicates LLC
  • Patent number: 7994336
    Abstract: The invention relates to novel azetidine compounds of formula (I), wherein R1, R2, and X are as described in the description and their use as orexin receptor antagonists.
    Type: Grant
    Filed: August 15, 2007
    Date of Patent: August 9, 2011
    Assignee: Actelion Pharmaceuticals Ltd.
    Inventors: Hamed Aissaoui, Christoph Boss, Markus Gude, Ralf Koberstein, Thierry Sifferlen